Trends in botanical dietary supplement use among US adults by cancer status: The National Health and Nutrition Examination Survey, 1999 to 2014

BACKGROUND Patients with cancer may use botanical dietary supplements (BDS) in an attempt to manage the side effects of chemotherapy, yet evidence about BDS use among patients with cancer is limited. The authors examined trends in BDS use among US adults according to cancer status and patient charac...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 2018-03, Vol.124 (6), p.1207-1215
Main Authors: Li, Chao, Hansen, Richard A., Chou, Chiahung, Calderón, Angela I., Qian, Jingjing
Format: Article
Language:English
Subjects:
Adult
Adults
Aged
botanical dietary supplements
Cancer
cancer survivors
Chemotherapy
Cross-Sectional Studies
Diet
Dietary Supplements
Education
Female
Health
Humans
Income
Male
Middle Aged
Minority & ethnic groups
National Health and Nutrition Examination Survey
Neoplasms - diet therapy
Nutrition
Nutrition Surveys - statistics & numerical data
Oncology
Patients
pharmacoepidemiology
Plant Extracts - administration & dosage
Regression analysis
Regression models
Self Report - statistics & numerical data
Side effects
Socioeconomic Factors
trend
Trends
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND Patients with cancer may use botanical dietary supplements (BDS) in an attempt to manage the side effects of chemotherapy, yet evidence about BDS use among patients with cancer is limited. The authors examined trends in BDS use among US adults according to cancer status and patient characteristics. METHODS A serial, cross‐sectional study was conducted using data from the National Health and Nutrition Examination Survey from 1999 through 2014 (n = 43,644). Self‐reported cancer diagnosis history and any BDS use in the preceding 30 days were determined. The prevalence of BDS use was calculated in each cycle for respondents with and without cancer, both overall and by patient characteristics. Simple linear regression models were applied to test for trends in BDS use at a 2‐sided P value 
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.31183